Baird Medical Investment Holdings Limited
BDMD
$3.16
$0.02450.78%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -1.12% | -1.12% | 85.81% | 85.81% | |
| Total Depreciation and Amortization | -5.85% | -5.85% | 28.61% | 28.61% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -0.57% | -0.57% | -88.51% | -88.51% | |
| Change in Net Operating Assets | -4.52% | -4.52% | -222.61% | -222.61% | |
| Cash from Operations | -41.48% | -41.48% | -715.93% | -715.93% | |
| Capital Expenditure | -72.40% | -72.40% | 61.66% | 61.66% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -- | |
| Cash from Investing | -72.40% | -72.40% | 61.66% | 61.66% | |
| Total Debt Issued | 64.55% | 64.55% | 134.36% | 134.36% | |
| Total Debt Repaid | -59.48% | -59.48% | -33.70% | -33.70% | |
| Issuance of Common Stock | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -69.21% | -69.21% | 89.16% | 89.16% | |
| Cash from Financing | 55.81% | 55.81% | 897.64% | 897.64% | |
| Foreign Exchange rate Adjustments | -341.67% | -341.67% | -244.93% | -244.93% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 51.91% | 51.91% | 99.31% | 99.31% | |